Rosemary Crane

Rosemary A. Crane is an Independent Director at Teva Pharmaceutical Industries Ltd. since 2015, an Independent Director at Certara, Inc. since 2022, Director-Discovery & Innovation at HMH Hospitals Corp, Inc., Director at Hackensack Meridian Health Center For Discovery & Innovation, and Member-Foundation Board at The State University of New York.
Former roles include President, Chief Executive Officer & Director at Epocrates LLC in 2011; President, Chief Executive Officer & Director at STRATA Skin Sciences, Inc. in 2014; President & Chief Executive Officer at Epocrates, Inc. (Research) in 2011; Group Chairman-OTC & Nutritional Group at Johnson & Johnson from 2006 to 2008; Vice Chairman at Zealand Pharma A from 2015 to 2019; Director at Cipher Pharmaceuticals, Inc. in 2016; Director at Targanta Therapeutics Corp.
from 2008 to 2009; Independent Director at Edge Therapeutics, Inc. from 2017 to 2019; Independent Director at Unilife Corp.
from 2016 to 2017; Director at Unilife Medical Solutions, Inc.; Independent Director at Catalent, Inc. from 2018 to 2024; Independent Director at Tarsus Pharmaceuticals, Inc. from 2021 to 2025; Director at Catalent Pharma Solutions, Inc. from 2018 to 2023; President-US Primary Care Division at Bristol Myers Squibb Co. from 2000 to 2002; and Partner at Apple Tree Venture Management LLC in 2013.
Education includes an undergraduate degree from State University of New York College at Oswego in 1981 and an MBA from Kent State University (Ohio) in 1986.